Jounce Therapeutics, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation expense
Net amortization of premiums and discounts on investments
Gain on sale of property and equipment
Changes in operating assets and liabilities:
Taxes receivable
Prepaid expenses and other current assets
Other non-current assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue—related party
Deferred rent
Other liabilities

Net cash used in operating activities
Investing activities:
Purchases of investments
Proceeds from maturities of investments
Proceeds from sales of investments
Purchases of property and equipment
Net cash provided by (used in) by investing activities

Financing activities:
Proceeds from initial public offering of common stock, net of issuance costs
Proceeds from at the market offering, net of issuance costs
Gilead Stock Purchase Agreement
Total proceeds from at the market offering, net of issuance costs
Proceeds from exercise of stock options
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accrued expenses
Stock option exercise receivables in prepaid expenses and other current assets
Issuance costs in accounts payable and accrued expenses
Discount on common stock issued under a stock purchase agreement
Supplemental cash flow information:
Cash paid for lease liabilities
Cash paid for income taxes

Comments